第五届欧洲生物转化研讨会会议报告
M Walles1, A Pähler2, E M Isin3
1Pharmacokinetic Sciences, Biomedical Research, Novartis, Basel, Switzerland.
Xenobiotica; the fate of foreign compounds in biological systems
|September 3, 2024
概括
本报告总结了第五届欧洲生物转化研讨会,强调了药物诱导性肝损伤 (DILI) 风险评估,寡核酸治疗生物转化和新型代谢物识别技术的进展.
科学领域:
- 药理学和药物新陈代谢
- 分析化学 分析化学
- 生物技术是生物技术.
背景情况:
- 第五届欧洲生物转化研讨会召集专家讨论生物转化当前的挑战和创新.
- 关注的重点领域包括药物代谢,代谢物识别和安全性评估.
- 研讨会为分享该领域最近的进展和未来方向提供了一个平台.
研究的目的:
- 总结第五届欧洲生物转化研讨会的主要演讲和讨论.
- 为突出了解与特定药物类相关的药物诱导性肝损伤 (DILI) 的最新进展.
- 审查生物转化和代谢物分析的新技术和战略.
主要方法:
- 对药物诱导性肝损伤 (DILI) 碳氧酸和共价抑制剂风险评估的陈述审查.
- 讨论基于寡核酸的治疗药物和自动化代谢物识别工具的生物转化途径.
- 评估最近代谢物合成的进展,并对新的低能加速器质谱 (LEA) 系统进行分析.
主要成果:
- 介绍了了解与碳酸和向共价抑制剂相关的DILI风险的进展.
- 讨论了对寡核酸治疗药物的生物转化新方法,包括代谢物识别软件.
- 报告了代谢物合成的进展以及对代谢物分析的紧LEA系统的成功验证.
结论:
- 研讨会强调了生物转化研究的重大进展,特别是药物安全性和新疗法.
- 新兴技术,如自动化代谢物识别和先进的质谱仪,对于未来的药物开发至关重要.
- 持续的合作和讨论对于应对生物转化方面的挑战和推进该领域至关重要.
关键词:
美国航空航天管理系统 (AMS)DILI 的风险是 DILI 的风险.用于MS的基因数据软件处理寡核酸的数据.不寻常的生物转化反应乙烯基CoA结合物是什么乙烯基葡萄糖化物 乙烯基葡萄糖化物寡核酸的生物转化质谱仪成像成像 质谱仪成像成像更多相关视频
13:16A Whole Cell Bioreporter Approach to Assess Transport and Bioavailability of Organic Contaminants in Water Unsaturated Systems
Published on: December 24, 2014
10.3K
12:47Workflow Based on the Combination of Isotopic Tracer Experiments to Investigate Microbial Metabolism of Multiple Nutrient Sources
Published on: January 22, 2018
9.4K
相关概念视频
Bioremediation
Bioremediation is the use of prokaryotes, fungi, or plants to remove pollutants from the environment. This process has been used to remove harmful toxins in groundwater as a byproduct of agricultural run-off and also to clean up oil spills.
Drug Biotransformation: Overview
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
Drug Biotransformation: Overview
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
Factors Affecting Drug Biotransformation: Biological
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Microbial Bioremediation of Hydrocarbons
Bioremediation is an environmentally sustainable process that employs living organisms—primarily microorganisms—to degrade or neutralize pollutants from contaminated environments. In oil spills and hydrocarbon pollution, bioremediation involves the use of hydrocarbon-degrading bacteria to transform toxic compounds into less harmful substances. This approach leverages natural microbial metabolic processes and is considered both cost-effective and ecologically favorable compared to physical or...
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
